Clinuvel Pharmaceuticals Ltd Capital Reinvestment Ratio
Clinuvel Pharmaceuticals Ltd capital reinvestment ratio. Clinuvel Pharmaceuticals Ltd (CUV) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$12.52 Million) in capital expenditures (AU$149.47K). Check how aggressively does Clinuvel Pharmaceuticals Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Clinuvel Pharmaceuticals Ltd (2017–2025)
Capital reinvestment ratio of Clinuvel Pharmaceuticals Ltd from 2017 to 2025. This chart tracks Clinuvel Pharmaceuticals Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset growth rate of Clinuvel Pharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Clinuvel Pharmaceuticals Ltd Capital Reinvestment Ratio by Year (2017–2025)
Clinuvel Pharmaceuticals Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see CUV cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | AU$41.10 Million | AU$298.57K | ▼ -95.2% |
| 2024 | 0.15x | AU$37.05 Million | AU$5.58 Million | ▲ +440.6% |
| 2023 | 0.03x | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.01x | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.04x | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.06x | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.01x | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$9.92 Million | AU$67.48K | — |